You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 280 No. 1, July 1, 1998 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (133)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Perinatal HIV-1 Transmission

Interaction Between Zidovudine Prophylaxis and Mode of Delivery in the French Perinatal Cohort

Laurent Mandelbrot, MD; Jérôme Le Chenadec, MS; Alain Berrebi, MD; André Bongain, MD; Jean-Louis Bénifla, MD; Jean-François Delfraissy, MD; Stéphane Blanche, MD; Marie-Jeanne Mayaux, BA; for the French Perinatal Cohort

JAMA. 1998;280:55-60.

Context.— It is unclear whether elective cesarean delivery may have a protective effect against the transmission of human immunodeficiency virus 1 (HIV-1).

Objective.— To investigate whether mode of delivery has an impact on perinatal HIV-1 transmission in the presence of zidovudine prophylaxis.

Design.— A prospective cohort study.

Setting.— The 85 perinatal centers in the French Perinatal Cohort, from 1985 to 1996.

Patients.— A total of 2834 singleton children born to mothers with HIV-1 infection.

Main Outcome Measure.— Human immunodeficiency virus 1 infection of the infant.

Results.— No zidovudine was used in 1917 pregnancies and zidovudine prophylaxis was used in 902 pregnancies. Cesarean deliveries were performed in 10.9% on an emergent basis and in 8.3% electively, prior to labor or membrane rupture. In 1917 mothers who did not receive zidovudine, of 1877 with information on mode of delivery, 17.2% transmitted HIV-1 to their child. Risk factors statistically significantly associated with transmission were maternal p24 antigenemia, cervicovaginal infections during pregnancy, amniotic fluid color, and rupture of membranes 4 hours or more before delivery. Mode of delivery was not related to transmission. In 902 mothers receiving zidovudine, transmission was 6.4% in 872 with information on mode of delivery, and elective cesarean delivery (n=133) was associated with a lower transmission rate than emergent cesarean or vaginal delivery (0.8%, 11.4%, and 6.6%, respectively; P=.002). In a multivariate analysis of all mother-child pairs, including obstetrical risk factors, maternal p24 antigenemia, and zidovudine prophylaxis, interaction between mode of delivery and zidovudine prophylaxis was significant (P=.007). In the multivariate analysis of pregnancies with zidovudine prophylaxis, factors related to transmission rate were maternal p24 antigenemia, amniotic fluid color, and mode of delivery. Adjusted odds ratios (95% confidence intervals) were 1.6 (0.7-3.6) for emergent cesarean delivery and 0.2 (0.0-0.9) for elective cesarean delivery (P=.04) in comparison with vaginal delivery.

Conclusions.— We observed an interaction between zidovudine prophylaxis and elective cesarean delivery in decreasing transmission of HIV-1 from mother to child. This observation may have clinical implications for prevention.


From the Service de Gynécologie-Obstétrique I, Hôpital Cochin-Port Royal and the Institut National de la Santé et de la Recherche Médicale (INSERM) U149, Paris, France (Dr Mandelbrot); INSERM U292, Kremlin-Bicêtre, France (Mr Le Chenadec and Ms Mayaux); Service de Gynécologie-Obstétrique, Hôpital de La Grave, Toulouse, France (Dr Berrebi); Service de Gynécologie-Obstétrique, Hôpital de L'Archet 2, Nice, France (Dr Bongain); Service de Gynécologie-Obstétrique, Hôpital Bichat, Paris (Dr Bénifla); Service de Médecine Interne, Hôpital de Kremlin-Bicêtre (Dr Delfraissy); and the Service de Pédiatrie, Hôpital Necker, Paris (Dr Blanche).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Unawareness of HIV status in pregnancy, delay in testing and conflict between information on antenatal card and interview in Recife, Brazil
de O X Ramos et al.
Int J STD AIDS 2009;20:493-498.
ABSTRACT | FULL TEXT  

Preventing Mother-to-Child Transmission of HIV in Resource-Limited Settings: The Elizabeth Glaser Pediatric AIDS Foundation Experience
Spensley et al.
AJPH 2009;99:631-637.
ABSTRACT | FULL TEXT  

Encouraging results despite complexity of multidisciplinary care of HIV-infected women using assisted reproduction techniques
Ohl et al.
Hum Reprod 2005;20:3136-3140.
ABSTRACT | FULL TEXT  

Decline in mortality in children with HIV in the UK and Ireland: Argument is flawed
Mhlongo and Maduna
BMJ 2004;328:523-523.
FULL TEXT  

Human Immunodeficiency Virus: Anesthetic and Obstetric Considerations
Evron et al.
Anesth. Analg. 2004;98:503-511.
ABSTRACT | FULL TEXT  

Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines)
Burdge et al.
CMAJ 2003;168:1671-1674.
FULL TEXT  

Assisted reproduction techniques for HIV serodiscordant couples: 18 months of experience
Ohl et al.
Hum Reprod 2003;18:1244-1249.
ABSTRACT | FULL TEXT  

Determinants of Mother-to-Infant Human Immunodeficiency Virus 1 Transmission Before and After the Introduction of Zidovudine Prophylaxis
The Italian Register for Human Immunodeficiency Vi
Arch Pediatr Adolesc Med 2002;156:915-921.
ABSTRACT | FULL TEXT  

HIV disease and respiratory infection in children
Graham and Gibb
Br Med Bull 2002;61:133-150.
ABSTRACT | FULL TEXT  

Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection
Lawn et al.
Clin. Microbiol. Rev. 2001;14:753-777.
ABSTRACT | FULL TEXT  

Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1
Mandelbrot et al.
JAMA 2001;285:2083-2093.
ABSTRACT | FULL TEXT  

Combination Prophylaxis for Prevention of Maternal-Infant HIV Transmission: Beyond 076
Shaffer
JAMA 2001;285:2129-2131.
FULL TEXT  

HIV transmission Prevention of Perinatal HIV-1 Transmission in the United States
Shetty and Maldonado
NeoReviews 2001;2:e83-93.
FULL TEXT  

Understanding the Timing of HIV Transmission From Mother to Infant
Kourtis et al.
JAMA 2001;285:709-712.
FULL TEXT  

Prevention of perinatal HIV transmission during pregnancy
McGowan and Shah
J Antimicrob Chemother 2000;46:657-668.
ABSTRACT | FULL TEXT  

False-Positive and Indeterminate Human Immunodeficiency Virus Test Results in Pregnant Women
Doran and Parra
Arch Fam Med 2000;9:924-929.
ABSTRACT | FULL TEXT  

Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data
Duong et al.
BMJ 1999;319:1227-1229.
ABSTRACT | FULL TEXT  

Labour care of women with HIV infection
Taylor et al.
BMJ 1999;319:381a-381.
FULL TEXT  

Risk Factors for Perinatal Transmission of Human Immunodeficiency Virus Type 1 in Women Treated with Zidovudine
Mofenson et al.
NEJM 1999;341:385-393.
ABSTRACT | FULL TEXT  

Maternal Levels of Plasma Human Immunodeficiency Virus Type 1 RNA and the Risk of Perinatal Transmission
Garcia et al.
NEJM 1999;341:394-402.
ABSTRACT | FULL TEXT  

Universal HIV screening of pregnant women in England: cost effectiveness analysis
Postma et al.
BMJ 1999;318:1656-1660.
ABSTRACT | FULL TEXT  

Prophylactic Cesarean Delivery for the Prevention of Perinatal Human Immunodeficiency Virus Transmission: The Case for Restraint
Stringer et al.
JAMA 1999;281:1946-1949.
FULL TEXT  

The Mode of Delivery and the Risk of Vertical Transmission of Human Immunodeficiency Virus Type 1 -- A Meta-Analysis of 15 Prospective Cohort Studies
The International Perinatal HIV Group
NEJM 1999;340:977-987.
ABSTRACT | FULL TEXT  

Short Courses of Zidovudine and Perinatal Transmission of HIV
Fiscus et al.
NEJM 1999;340:1040-1043.
FULL TEXT  

HIV Screening and Treatment of Pregnant Women and Their Newborns: A Simulation-Based Analysis
Anderson and Anderson
SIMULATION 1998;71:276-284.
ABSTRACT  

Elective Cesarean Sections Reduce Perinatal HIV Transmission
AIDS Clin Care 1998;1998:6-6.
FULL TEXT  

Cesarean Delivery for Prevention of HIV Transmission
JWatch Infect. Diseases 1998;1998:4-4.
FULL TEXT  

C-Section and HIV Transmission with Zidovudine
JWatch Women's Health 1998;1998:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.